BRIACELL THERAPEUTICS CORP. Intangible Assets, Net (Excluding Goodwill)
BRIACELL THERAPEUTICS CORP. (BCTX) had Intangible Assets, Net (Excluding Goodwill) of $180.71 thousand as of 2025-10-31, per its 10-Q filed 2025-12-11.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization
us-gaap:IntangibleAssetsNetExcludingGoodwill · last filed 2025-12-11
- 2025-10-31: Intangible Assets, Net (Excluding Goodwill) $180.71K.
- 2025-07-31: Intangible Assets, Net (Excluding Goodwill) $184.53K.
- 2025-04-30: Intangible Assets, Net (Excluding Goodwill) $188.34K.
- 2025-01-31: Intangible Assets, Net (Excluding Goodwill) $192.16K.
| Period end | Intangible Assets, Net (Excluding Goodwill) |
|---|---|
| 2025-10-31 | $180.71K 10-Q · filed 2025-12-11 |
| 2025-07-31 | $184.53K 10-Q · filed 2025-12-11 |
| 2025-04-30 | $188.34K 10-Q · filed 2025-06-16 |
| 2025-01-31 | $192.16K 10-Q · filed 2025-03-12 |
| 2024-10-31 | $195.98K 10-Q · filed 2024-12-16 |
| 2024-07-31 | $199.80K 10-K · filed 2025-10-16 |
| 2023-07-31 | $215.07K 10-K · filed 2024-10-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |